ABBVIE INC.

(ABBV)
  Rapport
Temps Différé Nyse  -  22:03 09/08/2022
140.25 USD   -0.06%
09/08Arecor obtient la protection d'un brevet européen pour une version à haute concentration de l'adalimumab d'AbbVie
MT
04/08BOURSE DE PARIS : La "Tech" en a marre de baisser
ZB
04/08EN DIRECT DES MARCHES : Crédit Agricole, SES, Equasens, Adecco, Adidas, Zalando, eBay, Bayer...
ZB
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteurAnalyses Zonebourse
Actualités dans d'autres langues sur ABBVIE INC.
09/08Few U.S. patients with hepatitis C get timely treatment, CDC says
09/08Arecor Granted EU Patent Protection for High-Concentration Version of AbbVie's Adalimum..
05/08FOCUS : 5 Stocks for Yield Lovers
04/08ABBVIE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF..
04/08AbbVie's Humira Patent Settlement Not A Violation Of Sherman Antitrust Act, Seventh Cir..
04/08GLOBAL MARKETS LIVE : Bayer, Merck, eBay, MetLife, Eli Lilly...
04/08FDA Approves JUVEDERM VOLUX XC for Improvement of Jawline Definition
04/08BOLSA DE MADRID : La tecnología está cansada de ir cuesta abajo
03/08AbbVie's Allergan Aesthetics Gets FDA Approval for Gel to Improve Jawline Definition
03/08FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition
02/08OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Gamesa, Heineken, Nestlé, HSBC, Delivery H..
02/08BOLSA DE MADRID : Hablando de nuevo de Taiwán
01/08AbbVie's Neutral Rating Maintained at Goldman Even as Skyrizi Sales Jump
01/08AbbVie - RINVOQ (upadacitinib) Approved by European Commission as an Oral Treatment for..
01/08AbbVie Reports Second-Quarter 2022 Financial Results
29/07Health Care Down After Mixed Earnings -- Health Care Roundup
29/07Apple en Amazon smaakmakers op groen Wall Street
29/07Wall Street koerst hoger
29/07AbbVie Posts Higher Second-Quarter Results, Revenue Misses Analyst Estimates
29/07AbbVie Down Over 6%, on Pace for Largest Percent Decrease Since September 2021 -- Data ..
29/07AbbVie's Allergan in Pact for Opioid Settlement, NC AG Says
29/07AbbVie Guides Q3 Revenue to $14.3 Bln vs $15.3 Bln Estimates
29/07Futures Wall Street dalen
29/07TRANSCRIPT : AbbVie Inc., Q2 2022 Earnings Call, Jul 29, 2022
29/07AKTIEN NEW YORK AUSBLICK : Starke Wochenbilanz - Apple und Amazon überzeugen
29/07Omzetstijging AbbVie schiet net tekort
29/07ABBVIE : Reports Second-Quarter 2022 Financial Results - Form 8-K
29/07AbbVie's Q2 Adjusted Earnings, Revenue Increase
29/07ABBVIE : Q2 Earnings Snapshot
29/07AbbVie sets aside $2 billion to settle U.S. opioid claims
29/07Earnings Flash (ABBV) ABBVIE Reports Q2 Revenue $14.58B
29/07Earnings Flash (ABBV) ABBVIE Posts Q2 EPS $3.37
29/07AbbVie Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
29/07Wall Street Leans Forward Pre-Bell; Futures Green, Europe Up, Asia Mixed
29/07Amerikaanse futures wijzen op hogere opening Wall Street
29/07NORTH AMERICAN MORNING BRIEFING : Apple, Amazon -2-
29/07AbbVie Gets Marketing Approval in Europe for Axial Spondyloarthritis Drug
29/07BOLSA DE MADRID : ¿Malas noticias? ¡Buenas noticias!
29/07RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults ..
29/07European Commission Approves Abbvie's Rinvoq® (Upadacitinib) as an Oral Treatment for A..
29/07BEURSAGENDA : buitenlandse fondsen
29/07Reuters-schedule/…
28/07BEURSAGENDA : buitenlandse fondsen
28/07AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ) in Croh..
28/07Wall Street opent iets lager na Fed-rally
28/07BEURSAGENDA : buitenlandse fondsen
28/07AbbVie's Allergan reaches $2 billion opioid lawsuit settlement - Bloomberg News
27/07BEURSAGENDA : buitenlandse fondsen
27/07AbbVie - European Commission Approves RINVOQ (upadacitinib) for the Treatment of Adults..
27/07Merck avoided billions in U.S. tax by offshoring Keytruda profits - senator
27/07AbbVie Submits Regulatory Applications to FDA, EMA for Upadacitinib to Treat Crohn's Di..
27/07AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib (RINVOQ®) in Cro..
27/07Abbvie Submits Regulatory Applications to U.S. Food and Drug Administration and Europea..
27/07AbbVie Seeks U.S., Europe OK of Rinvoq for Crohn's Disease
27/07BEURSAGENDA : buitenlandse fondsen
27/07AbbVie's Inflammatory Bowel Disease Drug Wins UK Approval
26/07BEURSAGENDA : buitenlandse fondsen
26/07NowVertical Up as Discloses Contract with AbbVie's Colombian Subsidiary for Data Aggreg..
26/07AbbVie Says Treatment for Ulcerative Colitis Rinvoq Approved By European Commission
26/07European Commission Approves RINVOQ® (upadacitinib) for the Treatment of Adults With Mo..
26/07AbbVie Announces European Commission Approves RINVOQ® (upadacitinib) for the Treatment ..
26/07BEURSAGENDA : buitenlandse fondsen
25/07BEURSAGENDA : buitenlandse fondsen
25/07AbbVie and Allergan Aesthetics to Present New Data from Leading Neurotoxin Portfolio at..
25/07BOLSA DE MADRID : Embotellamientos de verano
25/07BEURSAGENDA : buitenlandse fondsen
24/07Cijferseizoen en Fed trekken de aandacht
22/07BEURSAGENDA : buitenlandse fondsen
22/07BEURSAGENDA : buitenlandse fondsen
21/07BEURSAGENDA : buitenlandse fondsen
20/07Health Canada Approves AbbVie's RINVOQ® (upadacitinib) for the Treatment of Adults with..
20/07Health Canada Approves AbbVie's RINVOQ® (upadacitinib) for the Treatment of Adults with..
20/07AbbVie Collaborates With iStar Medical to Further Advance, Commercialize Glaucoma Thera..
20/07AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
20/07AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur ABBVIE INC.